For instance, the pattern of PRSS3 downregulation associated with the clinical relevance of HCC patients was similar to that of TMEM45A and VNN1, which are positively co-expressed genes of PRSS3 in HCC patients showing oncogenic effects on cancer-associated events (44, 45). The gene discussed is PRSS3; the disease is hepatocellular carcinoma.